blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1917227

EP1917227 - CRYSTAL FORMS OF ASTAXANTHIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.01.2014
Database last updated on 22.08.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Phares Drug Delivery AG
Kluenenfeldstrasse 30 PO Box 637
4132 Muttenz / CH
[2009/28]
Former [2008/19]For all designated states
PHARES PHARMACEUTICAL RESEARCH N.V.
P.O. Box 6052, Emancipatie Boulevard 31 Curacao
Netherlands Antilles / AN
Inventor(s)01 / LEIGH, Mathew, Louis, Steven
Hardstrasse 111
CH-4052 Basel / CH
02 / VAN HOOGEVEST, Peter
Breitenstrasse 3
CH-4416 Bubendorf / CH
03 / LEIGH, Steve
Phares Drug Delivery AG
Kluenenfeldstrasse 30
CH-4132 Muttenz / CH
 [2013/09]
Former [2008/19]01 / LEIGH, Mathew, Louis, Steven
Hardstrasse 111
CH-4052 Basel / CH
02 / VAN HOOGEVEST, Peter
Breitenstrasse 3
CH-4416 Bubendorf / CH
03 / LEIGH, Steve
Phares Drug Delivery AG Kluenenfeldstrasse 30
CH-4132 Muttenz / CH
Representative(s)Hasler, Erich, et al
c/o Riederer Hasler & Partner
Patentanwälte AG
Elestastrasse 8
7310 Bad Ragaz / CH
[N/P]
Former [2013/09]Hasler, Erich, et al
Riederer Hasler & Partner Patentanwälte AG Elestastrasse 8
7310 Bad Ragaz / CH
Former [2008/37]Hasler, Erich, et al
c/o Riederer Hasler & Partner, Patentanwälte AG, Elestastrasse 8
7310 Bad Ragaz / CH
Former [2008/19]Schreiber, Wolfgang, et al
Riederer Hasler & Partner Patentanwälte AG, Kappelestrasse 15
9492 Eschen / LI
Application number, filing date06776855.615.08.2006
[2008/19]
WO2006EP08047
Priority number, dateEP2005001770915.08.2005         Original published format: EP 05017709
[2008/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007020057
Date:22.02.2007
Language:EN
[2007/08]
Type: A1 Application with search report 
No.:EP1917227
Date:07.05.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 22.02.2007 takes the place of the publication of the European patent application.
[2008/19]
Type: B1 Patent specification 
No.:EP1917227
Date:27.02.2013
Language:EN
[2013/09]
Search report(s)International search report - published on:EP22.02.2007
ClassificationIPC:C07C49/653, A23L1/275
[2008/19]
CPC:
C07C403/24 (EP,NO,US); A23K50/80 (NO)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/19]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:KRISTALLFORMEN VON ASTAXANTHIN[2008/19]
English:CRYSTAL FORMS OF ASTAXANTHIN[2008/19]
French:FORMES CRISTALLINES D ASTAXANTHINE[2008/19]
Entry into regional phase23.01.2008National basic fee paid 
23.01.2008Designation fee(s) paid 
23.01.2008Examination fee paid 
Examination procedure23.01.2008Examination requested  [2008/19]
24.06.2011Despatch of a communication from the examining division (Time limit: M04)
27.09.2011Reply to a communication from the examining division
20.04.2012Despatch of a communication from the examining division (Time limit: M02)
19.06.2012Reply to a communication from the examining division
06.08.2012Communication of intention to grant the patent
05.12.2012Fee for grant paid
05.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.06.2011
Opposition(s)28.11.2013No opposition filed within time limit [2014/06]
Fees paidRenewal fee
23.01.2008Renewal fee patent year 03
21.07.2009Renewal fee patent year 04
12.08.2010Renewal fee patent year 05
10.08.2011Renewal fee patent year 06
13.08.2012Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.08.2006
AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
IE15.08.2013
LU15.08.2013
CH31.08.2013
LI31.08.2013
FR02.09.2013
[2015/34]
Former [2015/32]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
TR27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
IE15.08.2013
CH31.08.2013
LI31.08.2013
FR02.09.2013
Former [2014/37]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
IE15.08.2013
CH31.08.2013
LI31.08.2013
FR02.09.2013
Former [2014/33]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
IE15.08.2013
CH31.08.2013
LI31.08.2013
Former [2014/20]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
MC27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
CH31.08.2013
LI31.08.2013
Former [2014/03]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
IT27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
Former [2013/52]AT27.02.2013
BE27.02.2013
CY27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
Former [2013/49]AT27.02.2013
BE27.02.2013
CZ27.02.2013
EE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
RO27.02.2013
SE27.02.2013
SI27.02.2013
SK27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
Former [2013/40]AT27.02.2013
BE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
PT27.06.2013
Former [2013/38]AT27.02.2013
BE27.02.2013
FI27.02.2013
LT27.02.2013
LV27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
Former [2013/37]AT27.02.2013
FI27.02.2013
LT27.02.2013
PL27.02.2013
SE27.02.2013
SI27.02.2013
BG27.05.2013
GR28.05.2013
IS27.06.2013
Former [2013/36]AT27.02.2013
LT27.02.2013
PL27.02.2013
SE27.02.2013
BG27.05.2013
IS27.06.2013
Former [2013/34]LT27.02.2013
SE27.02.2013
BG27.05.2013
IS27.06.2013
Former [2013/33]LT27.02.2013
Cited inInternational search[XY]JPH07118226  (KURARAY CO) [XY] 1-34 * abstract *;
 [XY]EP0733619  (BASF AG [DE]) [XY] 1-34 * example 16 *;
 [XY]JPH1149972  (JIYUN INTERNATL KK, et al) [XY] 1-34 * abstract *;
 [XY]EP0978508  (HOFFMANN LA ROCHE [CH]) [XY] 1-34 * example - *;
 [XY]  - BUCHWALD M ET AL, "Optical properties of astaxanthin solutions and aggregates.", BIOCHEMISTRY. FEB 1968, (196802), vol. 7, no. 2, ISSN 0006-2960, pages 834 - 843, XP002408764 [XY] 1-34 * pages 1-2 *

DOI:   http://dx.doi.org/10.1021/bi00842a042
 [XY]  - HASHIMOTO, HIDEKI ET AL, "Molecular structures of carotenoids as predicted by MNDO-AM1 molecular orbital calculations", JOURNAL OF MOLECULAR STRUCTURE , 604(2-3), 125-146 CODEN: JMOSB4; ISSN: 0022-2860, (2002), XP002408765 [XY] 1-34 * pages 128,131 *

DOI:   http://dx.doi.org/10.1016/S0022-2860(01)00648-2
 [XY]  - WIDMER, ERICH ET AL, "Technical procedures for the synthesis of carotenoids and related compounds from oxoisophorone. I. Modification of the Kienzle-Mayer-synthesis of (3S,3'S)-astaxanthin", HELVETICA CHIMICA ACTA , 64(7), 2405 -18 CODEN: HCACAV; ISSN: 0018-019X, (1981), XP002408766 [XY] 1-34 * page 2417 *

DOI:   http://dx.doi.org/10.1002/hlca.19810640749
 [Y]  - MORISSETTE SHERRY L ET AL, "HIGH-THROUGHPUT CRYSTALLIZATION: POLYMORPHS, SALTS, CO-CRYSTALS AND SOLCATES OF PHARMACEUTICAL SOLIDS", ADVANCED DRUG DELIVERY REVIEWS, AMSTERDAM, NL, (2004), vol. 56, no. 3, ISSN 0169-409X, pages 275 - 300, XP009072233 [Y] 1-34 * pages 276-278 *

DOI:   http://dx.doi.org/10.1016/j.addr.2003.10.020
Examination   - COPPIN ET AL., ACTA CRYST., (2004), vol. A60, page S94
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.